- Chemoprevention of Gastric Cancer: Metformin
-
Kim YI, Cho SJ
- KMID: 2397491
- Korean J Helicobacter Up Gastrointest Res.
- 2017 Dec;17(4):179-184.
- doi: 10.7704/kjhugr.2017.17.4.179
Metformin is a first-line anti-diabetic drug that has been widely used in patients with type 2 diabetes. Many population-based epidemiologic studies have shown that metformin treatment is associated with decreased... -
- CITED
-
- Close
- SHARE
-
- Close
- Metformin and Cancer in Type 2 Diabetes
-
Park HK
- KMID: 2280712
- Diabetes Metab J.
- 2013 Apr;37(2):113-116.
- doi: 10.4093/dmj.2013.37.2.113
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Metformin Based Dual-Combination Therapies in Drug Naive Type 2 Diabetic Patients
-
Kim DL
- KMID: 2174224
- Diabetes Metab J.
- 2013 Dec;37(6):429-432.
- doi: 10.4093/dmj.2013.37.6.429
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Metformin for Treatment of Antipsychotic-Induced Amenorrhea in Female Schizophrenic Patients: Report of Two Cases
-
Woo YS, Bahk WM
- KMID: 2287452
- Korean J Psychopharmacol.
- 2013 Oct;24(4):186-189.
Amenorrhea is a common adverse event in female patients treated with antipsychotics. Because amenorrhea can produce difficulties for women suffering from schizophrenia, attempts should be made to alleviate antipsychotic-induced amenorrhea.... -
- CITED
-
- Close
- SHARE
-
- Close
- Protective and therapeutic effects of metformin on gynecologic cancers
-
Hwang JY
- KMID: 2374263
- J Gynecol Oncol.
- 2016 Nov;27(6):e61.
- doi: 10.3802/jgo.2016.27.e61
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Severe Acidosis after Massive Metformin Overdose
-
Kim BI, Jung JH, Eo EK
- KMID: 2203498
- J Korean Soc Clin Toxicol.
- 2008 Jun;6(1):42-44.
Metformin which is an oral hypoglycemic agents, acts by enhancing insulin sensitivity, decreasing hepatic glucose production and increasing peripheral utilization of glucose. Deliberate self poisoning with oral hypoglycemic agents is... -
- CITED
-
- Close
- SHARE
-
- Close
- Potential role for metformin in urologic oncology
-
Sayyid RK, Fleshner N
- KMID: 2426489
- Investig Clin Urol.
- 2016 May;57(3):157-164.
- doi: 10.4111/icu.2016.57.3.157
Metformin is one of the most commonly used drugs worldwide. It is currently considered first-line pharmacological agent for management of diabetes mellitus type 2. Recent studies have suggested that metformin... -
- CITED
-
- Close
- SHARE
-
- Close
- The Effect of Rosiglitazone and Metformin Therapy, as an Initial Therapy, in Patients with Type 2 Diabetes Mellitus
-
Kim DL
- KMID: 2222462
- Korean Diabetes J.
- 2008 Dec;32(6):532-533.
- doi: 10.4093/kdj.2008.32.6.532
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- What Is the Effect of Metformin Combined to Chemotherapy in Stage IV Colorectal Cancer with Diabetes?
-
Jung JT
- KMID: 1773068
- Korean J Gastroenterol.
- 2012 Dec;60(6):343-344.
- doi: 10.4166/kjg.2012.60.6.343
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Letter: Economic Impact of Combining Metformin with Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients with Renal Impairment in Spanish Patients (Diabetes Metab J 2015;39:74-81)
-
Seok H
- KMID: 1805901
- Diabetes Metab J.
- 2015 Apr;39(2):171-172.
- doi: 10.4093/dmj.2015.39.2.171
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Letter: Efficacy and Safety of Voglibose Plus Metformin in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial (Diabetes Metab J 2019;43;276-86)
-
Seok H, Sohn TS
- KMID: 2455677
- Diabetes Metab J.
- 2019 Aug;43(4):545-546.
- doi: 10.4093/dmj.2019.0130
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Response: Economic Impact of Combining Metformin with Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients with Renal Impairment in Spanish Patients (Diabetes Metab J 2015;39:74-81)
-
Sicras-Mainar A, Navarro-Artieda R
- KMID: 1805902
- Diabetes Metab J.
- 2015 Apr;39(2):173-174.
- doi: 10.4093/dmj.2015.39.2.173
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Effects of Metformin and Rosiglitazone in Overweight or Obese Women with Polycystic Ovarian Syndrome
-
Bai KB
- KMID: 1772295
- Korean J Fertil Steril.
- 2005 Dec;32(4):347-352.
OBJECTIVE: The purpose of this study was to evaluate and compare the effects of metformin and rosiglitazone in overweight or obese women with polycystic ovarian syndrome. METHODS: Twenty Six overweight or... -
- CITED
-
- Close
- SHARE
-
- Close
- Outcome of Early Diagnos is and Hemodialys is in Acute Renal Failure due to Metformin-associated Lactic Acidosis in Elderly Type 2 Diabetes Mellitus Patient
-
Bong JD, Kwak SH, Boo KB, Sim DS, Lee TW
- KMID: 2015108
- J Korean Geriatr Soc.
- 2004 Jun;8(2):115-118.
Metformin is a biguanide oral hypoglycemic agent commonly used in the treatment of diabetes mellitus. Metfofmin is excreated largely by the kidney and binds only negligibly to plasma proteins. Toxicity... -
- CITED
-
- Close
- SHARE
-
- Close
- Letter: Dipeptidyl Peptidase-4 Inhibitors versus Other Antidiabetic Drugs Added to Metformin Monotherapy in Diabetic Retinopathy Progression: A Real World-Based Cohort Study (Diabetes Metab J 2019;43:640–8)
-
Moon JS
- KMID: 2466513
- Diabetes Metab J.
- 2019 Dec;43(6):911-912.
- doi: 10.4093/dmj.2019.0207
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Inhibitory Effect of Metformin Therapy on the Incidence of Colorectal Advanced Adenomas in Patients With Diabetes
-
Kim YH, Noh R, Cho SY, Park SJ, Jeon SM, Shin HD, Kim SB, Shin JE
- KMID: 2284881
- Intest Res.
- 2015 Apr;13(2):145-152.
- doi: 10.5217/ir.2015.13.2.145
BACKGROUND/AIMS: Metformin use has been associated with decreased colorectal cancer risk and mortality among diabetic patients. Recent research suggests that metformin use may decrease the incidence of colorectal adenomas in... -
- CITED
-
- Close
- SHARE
-
- Close
- Metformin Suppresses MHC-Restricted Antigen Presentation by Inhibiting Co-Stimulatory Factors and MHC Molecules in APCs
-
Shin S, Hyun B, Lee A, Kong H, Han S, Lee CK, Ha NJ, Kim K
- KMID: 2170683
- Biomol Ther.
- 2013 Jan;21(1):35-41.
Metformin is widely used for T2D therapy but its cellular mechanism of action is undefined. Recent studies on the mechanism of metformin in T2D have demonstrated involvement of the immune... -
- CITED
-
- Close
- SHARE
-
- Close
- The Effect of Metformin in Obese Pediatric Patients with Type 2 Diabetes
-
Jung HH, Kim TH, Kim DH
- KMID: 1520743
- J Korean Soc Pediatr Endocrinol.
- 2007 Dec;12(2):127-134.
PURPOSE: Metformin is well-established oral hypoglycemic agent for adults and children with type 2 diabetes mellitus. In adults, metformin is effective as initial monotherapy with lack of weight gain. But,... -
- CITED
-
- Close
- SHARE
-
- Close
- Metformin for Lithium-induced Weight Gain: A Case Report
-
Praharaj S
- KMID: 2171008
- Clin Psychopharmacol Neurosci.
- 2016 Feb;14(1):101-103.
- doi: 10.9758/cpn.2016.14.1.101
Lithium is the first line treatment for maintenance treatment of bipolar disorder. Among the long term adverse effects, weight gain is likely to affect a subset of patients. There is... -
- CITED
-
- Close
- SHARE
-
- Close
- Monotherapy in Type 2 Diabetes Mellitus Patients 2017: A Position Statement of the Korean Diabetes Association
-
Rhee SY
- KMID: 2408653
- J Korean Diabetes.
- 2018 Mar;19(1):15-22.
- doi: 10.4093/jkd.2018.19.1.15
When starting initial medication in people with type 2 diabetes mellitus (T2DM), the appropriate drug should be selected considering characteristics of the patient, efficacy, side effects, and cost. It is... -
- CITED
-
- Close
- SHARE
-
- Close
